Ropinirole
NDC 64850-250, Ropinirole, tablet, extended release, from Elite Laboratories, Inc..
- Product NDC
- 64850-250
- Status
- Listed
- Labeler
- Elite Laboratories, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217862
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64850-250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROPINIROLE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Dopamine Agonists [MoA]; Nonergot Dopamine Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64850-250-30 | 64850025030 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (64850-250-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/307411be-1c4e-44f7-b94d-737a3384c107NADAC price for package 64850025030
GET /v1/drugs/nadac/64850025030
Use it
Look up 64850-250 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64850-250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64850-250. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.